Genes, Environment And Disease Converge In Two Major NIH Initiatives
This article was originally published in The Pink Sheet Daily
The research initiatives will be sponsored by NIH, the Foundation for NIH, Pfizer and biotech company Affymetrix.
You may also be interested in...
The method uses a combination of advanced chemical analysis and mathematical modeling to predict drug response.
More than one in four National Cancer Institute-funded scientists start their own healthcare companies based on their own discoveries.
U.S. overtakes Europe in innovation between 1993 and 2003, introducing the most first-in-class, biotech and orphan products in the global market, according to a study authored by a Duke University economics professor